Evidence map›Paper›PMID 40647440›Full record

ArticleCancers2025

A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study).

Francesco Deodato, Gabriella Macchia, Patrick Duhanxhiu, Filippo Mammini, Letizia Cavallini, Maria Ntreta, Arina Alexandra Zamfir, Milly Buwenge, Francesco Cellini, Selena Ciabatti and 6 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francesco DeodatoRadiotherapy Unit, Responsible Research Hospital, 86100 Campobasso, Italy.ORCID 0000-0003-1276-5070
Gabriella MacchiaRadiotherapy Unit, Responsible Research Hospital, 86100 Campobasso, Italy.ORCID 0000-0002-0529-201X
Patrick DuhanxhiuRadiation Oncology, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-Bologna University, 40138 Bologna, Italy.
Filippo MamminiRadiation Oncology, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-Bologna University, 40138 Bologna, Italy.
Letizia CavalliniRadiation Oncology Unit, Radiotherapy Department, Santa Maria della Misericordia Hospital, ULSS5, 45100 Rovigo, Italy.
Maria NtretaRadiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Arina Alexandra ZamfirRadiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0009-0008-9966-6342
Milly BuwengeRadiation Oncology, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-Bologna University, 40138 Bologna, Italy.
Francesco CelliniDipartimento Universitario Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.ORCID 0000-0002-2145-2300
Selena CiabattiRadiation Oncology Department, Bellaria Hospital, AUSL of Bologna, 40139 Bologna, Italy.
Lorenzo BianchiDivision of Urology, IRCCS Azienza Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Riccardo SchiavinaDivision of Urology, IRCCS Azienza Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Eugenio BrunocillaDivision of Urology, IRCCS Azienza Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Elisa D'AngeloRadiation Oncology Department, Bellaria Hospital, AUSL of Bologna, 40139 Bologna, Italy.ORCID 0000-0002-5954-0939
Alessio Giuseppe MorgantiRadiation Oncology, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-Bologna University, 40138 Bologna, Italy.ORCID 0000-0001-9793-3410
Savino CillaMedical Physics Unit, Responsible Research Hospital, 86100 Campobasso, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to develop a predictive model for acute gastrointestinal (GI) and genitourinary (GU) toxicity in prostate cancer patients treated with salvage radiotherapy (SRT) post-prostatectomy, using machine learning techniques to identify key prognostic factors.

methodsA multicenter retrospective study analyzed 454 patients treated with SRT from three Italian radiotherapy centers. Acute toxicity was assessed using Radiation Therapy Oncology Group criteria. Predictors of grade ≥ 2 toxicity were identified through Least Absolute Shrinkage and Selection Operator (LASSO) regression and Classification and Regression Tree (CART) modeling. The analyzed variables included surgical technique, clinical target volume (CTV) to planning target volume (PTV) margins, extent of lymphadenectomy, radiotherapy technique, and androgen-deprivation therapy (ADT).

resultsNo patients experienced grade ≥ 4 toxicity, and grade 3 toxicity was below 1% for both GI and GU events. The primary determinant of acute toxicity was the surgical technique. Open prostatectomy was associated with significantly higher grade ≥ 2 GI (41.8%) and GU (35.9%) toxicity compared to laparoscopic/robotic approaches (18.9% and 12.2%, respectively). A CTV-to-PTV margin ≥ 10 mm further increased toxicity, particularly when combined with extensive lymphadenectomy. SRT technique and ADT were additional predictors in some subgroups.

conclusionsSRT demonstrated excellent tolerability. Surgical technique, CTV-to-PTV margin, and treatment parameters were key predictors of toxicity. These findings emphasize the need for personalized treatment strategies integrating surgical and radiotherapy factors to minimize toxicity and optimize outcomes in prostate cancer patients.

Indexed as

acute toxicityandrogen-deprivation therapygastrointestinal toxicitygenitourinary toxicityLASSO regressionmachine learningplanning target volumepredictive modelprostate cancersalvage radiotherapy

Identifiers

PMID40647440
PMCPMC12249318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.